Insomnia

Insomnia
Name	Insomnia
Field	Sleep medicine, Neurology, Psychiatry
Symptoms	Difficulty initiating sleep, difficulty maintaining sleep, early morning awakening
Complications	Daytime fatigue, impaired functioning, mood disorders

Insomnia Insomnia is a common sleep disorder characterized by persistent difficulty with sleep initiation, sleep maintenance, or restorative sleep that causes daytime impairment. It is recognized across clinical specialties including Neurology, Psychiatry, Primary care, and Pulmonology, and is commonly addressed in guidelines from organizations such as the American Academy of Sleep Medicine, the National Institutes of Health, and the World Health Organization. Presentation varies by age and comorbidity and often requires multidisciplinary assessment involving clinicians from Internal Medicine, Geriatrics, Pediatrics, and Behavioral therapy teams.

Definition and classification

Insomnia is classified in major nosologies including the International Classification of Diseases (ICD) and the Diagnostic and Statistical Manual of Mental Disorders (DSM) as a disorder of sleep characterized by subjective complaints of poor sleep quantity or quality. Subtypes include acute, chronic, and comorbid insomnia, and phenotypes may be described by sleep onset insomnia, sleep maintenance insomnia, or early morning awakening. Nosological frameworks intersect with criteria from organizations such as the American Psychiatric Association, the World Health Organization, and the American Academy of Sleep Medicine, and diagnostic coding uses systems maintained by the Centers for Disease Control and Prevention and national health services like the National Health Service.

Epidemiology and risk factors

Epidemiological estimates derive from cohort studies and surveys conducted by institutions such as the National Institutes of Health, the Centers for Disease Control and Prevention, and academic centers including Harvard Medical School, University of Oxford, and Johns Hopkins University. Prevalence varies by region, with higher rates reported in community cohorts studied in the United States, United Kingdom, Australia, and parts of Europe. Risk factors include advancing age, female sex, psychiatric comorbidity such as Major depressive disorder and Generalized anxiety disorder, medical comorbidities treated by specialists at institutions like Mayo Clinic and Cleveland Clinic, shift work patterns found in employees of Federal Aviation Administration-regulated industries, and lifestyle contributors identified in population studies from World Health Organization surveillance.

Causes and pathophysiology

Etiology is multifactorial with contributions from psychiatric disorders (for example, Major depressive disorder, Bipolar disorder, Post-traumatic stress disorder), medical disorders managed by Cardiology and Endocrinology such as chronic pain syndromes and thyroid disease, neurologic conditions treated in Neurology clinics including Parkinson's disease and Alzheimer's disease, and circadian rhythm disruptions exemplified by shift work among employees of organizations like NASA and Royal Air Force. Neurobiological models implicate arousal systems in the brainstem and hypothalamus studied in laboratories at institutions such as MIT and Stanford University, with neurotransmitter systems including gamma-aminobutyric acid and monoamines. Genetic studies by consortia including the International Sleep Genomics Consortium and large biobanks such as the UK Biobank implicate polygenic risk and overlap with loci associated with psychiatric phenotypes cataloged by groups like the Psychiatric Genomics Consortium.

Symptoms and diagnosis

Clinical features include difficulty initiating sleep, frequent nocturnal awakenings, nonrestorative sleep, and impaired daytime function such as fatigue, cognitive slowing, and mood lability referenced in guidelines from the American Academy of Sleep Medicine and the Royal College of Psychiatrists. Diagnostic evaluation incorporates sleep history, standardized instruments like the Insomnia Severity Index validated in trials at centers including University of Pennsylvania and Columbia University, sleep diaries used in longitudinal studies by King's College London, and objective testing such as polysomnography performed in sleep laboratories conforming to standards from the American Academy of Sleep Medicine. Differential diagnosis involves ruling out sleep-disordered breathing (diagnosed by teams at Johns Hopkins University), restless legs syndrome described in research from Karolinska Institute, and circadian rhythm disorders characterized in shift-work studies by institutions such as National Institute for Occupational Safety and Health.

Management and treatment

Management is multimodal and guided by randomized trials and clinical practice guidelines produced by bodies including the American Academy of Sleep Medicine, the National Institute for Health and Care Excellence, and the European Sleep Research Society. First-line therapy for chronic insomnia is cognitive behavioral therapy for insomnia (CBT-I) delivered by clinicians trained in programs at University of Pennsylvania and University of Michigan, with components including stimulus control, sleep restriction, cognitive restructuring, and relaxation techniques. Pharmacologic options include short-term use of hypnotics such as benzodiazepines evaluated in trials at Mayo Clinic and non-benzodiazepine sedative-hypnotics studied at Vanderbilt University Medical Center, as well as off-label use of agents prescribed by psychiatrists and neurologists at tertiary centers like Massachusetts General Hospital. Adjunctive approaches include chronotherapy, light therapy developed in research at University of Toronto, and management of comorbidities by specialists at institutions such as Cleveland Clinic and Mount Sinai Hospital.

Prognosis and complications

Prognosis depends on duration, underlying causes, and response to interventions; chronic courses are common in cohorts followed by research groups at Brigham and Women's Hospital and University College London. Complications include increased risk of psychiatric disorders including Major depressive disorder and Anxiety disorders, impaired occupational functioning documented in occupational health studies at Occupational Safety and Health Administration-associated archives, cardiovascular risk associations studied by investigators at Framingham Heart Study, and reduced quality of life assessed in surveys by World Health Organization. Effective treatment, particularly CBT-I programs implemented in health systems such as the Veterans Health Administration and primary care pathways in the National Health Service, improves sleep outcomes and mitigates many downstream risks.

Category:Sleep disorders